<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03625713</url>
  </required_header>
  <id_info>
    <org_study_id>IST</org_study_id>
    <nct_id>NCT03625713</nct_id>
  </id_info>
  <brief_title>Bacterial Ano-rectitis Sexually Transmitted in a Specialized Consultation Center</brief_title>
  <acronym>IST</acronym>
  <official_title>Epidemiological, Clinical, Microbiological and Therapeutic Aspects of Sexually Transmitted Bacterial Ano-rectitis in a Specialized Consultation Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infectious ano-rectitis is poorly described. Their epidemiology is poorly known, as are their
      clinical, diagnostic (diagnoses are regularly corrected in gastroenterology and new
      diagnostic tools are now available) and therapeutic aspects.

      Analysis of data from this large population of patients referred to the proctology center for
      suspicion of Neisseria gonorrhoeae and / or Chlamydia trachomatis ano-rectitis will help
      identify risk factors and target prevention strategies and optimized therapeutic management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 20, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the clinical presentation</measure>
    <time_frame>Day 1</time_frame>
    <description>Prevalence of clinical signs : fever (yes/no), ulcerations (yes/no), purulent proctisis (yes/no), erythematosus proctisis (yes/no), condyloma (yes/no)</description>
  </primary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Ano-Rectal Infection Bacterial Nos</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population corresponds to patients seen in hospital, in emergency consultation or
        programmed for a suspicion of infectious ano-rectitis and for whom a sampling for
        diagnostic purposes will be carried out and addressed in microbiology.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient over the age of 18

          -  Patient consulting or hospitalized in the proctology center

          -  Patient for whom an anorectal sampling will be performed for suspicion of sexually
             transmitted infectious ano-rectitis

        Exclusion Criteria:

          -  Patient's opposition to participate

          -  Patient deprived of liberty

          -  Patient under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent De Parades, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Paris Saint Joseph</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincent De Parades, MD</last_name>
    <phone>0144127469</phone>
    <email>vdeparades@hpsj.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Groupe Hospitalier Paris Saint-Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène BEAUSSIER, PhD, PharmD</last_name>
      <phone>0144127038</phone>
      <email>crc@hpsj.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 13, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2018</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

